HPLC-certified Apitoxin sourced from Apis mellifera. Verified by Ph.D. scientists and suited for pharmaceutical, cosmetic, neurology, and apitherapy B2B applications globally.
Umbrella Pharmaceuticals LLC is a pharmaceutical-grade bee venom producer based in Alexandria, Egypt — a region with centuries of apiculture heritage. Our products are developed, tested, and certified by credentialed scientists with deep expertise in food science and apitherapy.
We supply B2B clients across pharmaceutical, cosmetic, nutraceutical, and research sectors, offering full analytical transparency through HPLC certification and independently verifiable Certificates of Analysis.
Full product identity for Bee Venom Powder (Apitoxin) as tested and certified by Umbrella Pharmaceuticals.
| Parameter | Details |
|---|---|
| Product Name | Bee Venom Powder (Apitoxin) |
| Form | Dry Powder |
| Source | Honeybee (Apis mellifera) |
| Test Method | HPLC (High-Performance Liquid Chromatography) |
| Supplier / Lab | Umbrella Pharmaceuticals LLC — Alexandria, Egypt |
| Test Date | 01/03/2024 |
| Certified By | Dr. Samir Youssef, Ph.D. Food Science |
| Storage | Cool, dry, dark — 0°C. Dry powder is inherently stable; avoid moisture. |
All values certified via HPLC — reproducible, transparent, and independently verifiable. Total identified: 67.1% (remaining ~33% includes other peptides, enzymes, histamine, volatiles, and minerals).
Bee venom powder has demonstrated efficacy across a broad spectrum of medical, cosmetic, and research domains.
These points must be communicated to end-users and should be included in B2B supply contracts.
Key differentiators for procurement teams and commercial discussions.
Reach out for product inquiries, sample requests, pricing, or full technical documentation.